Last Thursday and Friday, FDA's Pharmacy Compounding Advisory Committee reviewed seven nominated peptides and recommended six of them for inclusion on the 503A bulk drug substances list: Thursday: BPC-157, KPV, TB-500, and MOTS-c Friday: Epitalon and Semax Not recommended: Emideltide (DSIP) Worth keeping in perspective: these votes are recommendations, not approvals
Glutathione Supplements For those looking to increase their glutathione levels more directly, supplements are available in various forms: Oral Supplements : These can help boost glutathione levels, although their effectiveness can vary due to absorption rates
A patient with recurrent infections and low class-switched memory B cells
Clinical research Research published in the Journal of Pharmacology and Experimental Therapeutics (McCoy et al., 2013) evaluated metabolically stabilized angiotensin IV analogs, including Dihexa, as pro-cognitive and anti-dementia agents, demonstrating meaningful cognitive improvements in animal models
There is increased risk in patients whose ability to maintain blood pressure has already been compromised by a reduced blood volume or concurrent administration of certain CNS depressant drugs (e.g., phenothiazines or general anesthetics) [see PRECAUTIONS
some dairy products, like cheese and yogurt